Antidepressant efficacy of ketamine in treatment-resistant major depression: a two-site randomized controlled trial

JW Murrough, DV Iosifescu, LC Chang… - American Journal of …, 2013 - Am Psychiatric Assoc
Objective Ketamine, a glutamate N-methyl-d-aspartate (NMDA) receptor antagonist, has
shown rapid antidepressant effects, but small study groups and inadequate control …

[PDF][PDF] Antidepressant Efficacy of Ketamine in Treatment-Resistant Major Depression: A Two-Site Randomized Controlled Trial

JW Murrough, DV Iosifescu, LC Chang… - Am J …, 2013 - cdn.copepsychiatry.com
Objective—Ketamine, a glutamate N-methyl-D-aspartate (NMDA) receptor antagonist, has
shown rapid antidepressant effects, but small study groups and inadequate control …

[PDF][PDF] Antidepressant Efficacy of Ketamine in Treatment-Resistant Major Depression: A Two-Site Randomized Controlled Trial

JW Murrough, DV Iosifescu, LC Chang… - Am J …, 2013 - relevarecare.com
Objective—Ketamine, a glutamate N-methyl-D-aspartate (NMDA) receptor antagonist, has
shown rapid antidepressant effects, but small study groups and inadequate control …

[PDF][PDF] Antidepressant Efficacy of Ketamine in Treatment-Resistant Major Depression: A Two-Site Randomized Controlled Trial

JW Murrough, DV Iosifescu, LC Chang, RK Al Jurdi… - Am J …, 2013 - citclinics.com
Objective—Ketamine, a glutamate N-methyl-D-aspartate (NMDA) receptor antagonist, has
shown rapid antidepressant effects, but small study groups and inadequate control …

[PDF][PDF] Antidepressant Efficacy of Ketamine in Treatment-Resistant Major Depression: A Two-Site Randomized Controlled Trial

JW Murrough, DV Iosifescu, LC Chang… - Am J …, 2013 - findpainrelief.com
Objective: Ketamine, a glutamate N-methyl-D-aspartate (NMDA) receptor antagonist, has
shown rapid antidepressant effects, but small study groups and inadequate control …

[引用][C] Antidepressant Efficacy of Ketamine in Treatment-Resistant Major Depression: A Two-Site Randomized Controlled Trial

JW MURROUGH, DV IOSIFESCU… - … American journal of …, 2013 - pascal-francis.inist.fr
Antidepressant Efficacy of Ketamine in Treatment-Resistant Major Depression: A Two-Site
Randomized Controlled Trial CNRS Inist Pascal-Francis CNRS Pascal and Francis …

[引用][C] Antidepressant Efficacy of Ketamine in Treatment-Resistant Major Depression: A Two-Site Randomized Controlled Trial

JW Murrough, DV Iosifescu, LC Chang… - American Journal of …, 2013 - cir.nii.ac.jp
Antidepressant Efficacy of Ketamine in Treatment-Resistant Major Depression: A Two-Site
Randomized Controlled Trial | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ …

[HTML][HTML] Antidepressant Efficacy of Ketamine in Treatment-Resistant Major Depression: A Two-Site Randomized Controlled Trial

JW Murrough, DV Iosifescu, LC Chang… - The American journal …, 2013 - ncbi.nlm.nih.gov
Objective Ketamine, a glutamate N-methyl-d-aspartate (NMDA) receptor antagonist, has
shown rapid antidepressant effects, but small study groups and inadequate control …

[PDF][PDF] Antidepressant Efficacy of Ketamine in Treatment-Resistant Major Depression: A Two-Site Randomized Controlled Trial

JW Murrough, DV Iosifescu, LC Chang… - Am J …, 2013 - boiseketamine.com
Objective: Ketamine, a glutamate N-methyl-D-aspartate (NMDA) receptor antagonist, has
shown rapid antidepressant effects, but small study groups and inadequate control …

Antidepressant efficacy of ketamine in treatment-resistant major depression: A two-site randomized controlled trial.

JW Murrough, DV Iosifescu, LC Chang… - The American Journal …, 2013 - psycnet.apa.org
Objective: Ketamine, a glutamate N-methyl-D-aspartate (NMDA) receptor antagonist, has
shown rapid antidepressant effects, but small study groups and inadequate control …